Brokerages Set 9 Meters Biopharma, Inc. (NASDAQ:NMTR) Target Price at $45.57 : vimarsana.com

Shares of 9 Meters Biopharma, Inc. (NASDAQ:NMTR – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 […]

Related Keywords

, Meters Biopharma Company Profile , Vanguard Group Inc , Meters Biopharma Inc , Nasdaq , Citigroup , Millennium Management , Renaissance Technologies , Get Rating , Marketbeat Ratings , Brookline Capital Management , Biopharma Trading Down , Capital Management , Two Sigma Investments , Sigma Investments , Biopharma Company , Biopharma Daily , 9 Meters Biopharma , Nasdaq Nmtr , Nmtr , Medical , Ratings , Consensus ,